Background: The management of cancer patients often includes palliative care to improve their quality of life. This study investigates the potential role of homeopathic medicines as an adjunctive therapy in this context. Objective: The primary objective was to evaluate the efficacy of homeopathic treatment in improving the quality of life of cancer patients under palliative care, using the Global Health Status (GHS) score of the EORTC QLQ-C30 questionnaire as the primary outcome measure. Methods: This was a prospective study involving 30 cancer patients. Each patient's GHS score was measured at baseline (before treatment) and after a period of homeopathic intervention. A paired t-test was used to statistically analyze the difference between the pre- and post-treatment scores. Result: The average GHS score for the cohort significantly improved from 47.33 before treatment to 61.33 after treatment. The statistical analysis showed a significant increase in the GHS scores, with a t-statistic of 2.89 and a p-value of 0.0073. The treatment outcome was positive for the majority of the patients, with 22 cases showing improvement, 3 remaining stable, and 5 not improving. Conclusion: Homeopathic medicines demonstrated a statistically significant improvement in the quality of life of cancer patients under palliative care. These findings suggest that homeopathy may be a beneficial and effective complementary approach for managing the symptoms and enhancing the well-being of this patient population.
